observational
    2011

    Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

    Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL

    Published in Cancer Chemotherapy and Pharmacology

    Key Findings

    Pterostilbene showed roughly 80 percent oral bioavailability versus about 20 percent for resveratrol in rats.

    Conclusions

    Superior bioavailability underpins interest in pterostilbene over resveratrol.

    Limitations

    Animal pharmacokinetic study; human translation unproven.

    Supplements Studied

    Pterostilbene showed roughly 80 percent oral bioavailability versus about 20 percent for resveratrol in rats.

    Resveratrol
    Compound

    Pterostilbene showed roughly 80 percent oral bioavailability versus about 20 percent for resveratrol in rats.

    Study Details

    Year:2011
    00
    Quality Score:4/10

    Access Study

    View on DOIOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.